RJA
IFRX icon

Raymond James & Associates’s InflaRx IFRX Stock Holding History

Raymond James & Associates’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,000
Closed -$8K – 4142
2021
Q1 		$8K Sell
15,000
-3,000
-17% -$15.4K ﹤0.01% 3961
2020
Q4 		$11K Sell
18,000
-1,500
-8% -$6.75K ﹤0.01% 3727
2020
Q3 		$14K Buy
+19,500
New +$89.8K ﹤0.01% 3525

Other funds holding IFRX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Raymond James & Associates's IFRX Position: Q3 2024 in Review

Raymond James & Associates reduced its InflaRx (IFRX) stake by 8.5% in Q3 2024, selling an estimated $37.7K and leaving 267,075 shares worth $409K. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

Raymond James & Associates first reported a position in IFRX in Q3 2020 and has held it in 17 quarters since. The position peaked at $611K in Q2 2023. 27 funds tracked by Wall St. Rank hold IFRX as of Q3 2024.

  • Raymond James & Associates held 267,075 shares of InflaRx worth $409K as of Q3 2024.
  • Raymond James & Associates sold 24,774 InflaRx shares in Q3 2024, an estimated $37.7K.
  • InflaRx made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3222 holding.
  • Raymond James & Associates first reported a position in InflaRx in Q3 2020 and has held it in 17 quarters since.
  • Raymond James & Associates's InflaRx position peaked at $611K in Q2 2023.
  • 27 funds tracked by Wall St. Rank held InflaRx as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.